Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.66 |
| ▸ | HPGD | P15428 | 1/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | BLM | P54132 | 1/20 | 0.66 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28755565 | 1.00 | TRPV1 (0.74) | TRPV1ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL29530847 | 1.00 | TRPV1 (0.74) | TRPV1ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL9808706 | 1.00 | TRPV1 (0.74) | TRPV1ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL29380151 | 0.93 | TRPV1 (0.70) | TRPV1ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL504255 | 0.93 | TRPV1 (0.70) | TRPV1ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL504257 | 0.93 | TRPV1 (0.70) | TRPV1ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL9808674 | 0.93 | TRPV1 (0.70) | TRPV1ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL9808719 | 0.92 | ALDH1A1 (0.64) | TRPV1ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL1586047 | 0.91 | TRPV1 (0.67) | TRPV1ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL29530867 | 0.90 | L3MBTL1 (0.73) | TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1517880-B1 | PRODUCTION OF CIS-PELLITORIN AND USE AS A FLAVOURING | SYMRISE AG (DE) | 2011-01-05 | — | — | EP | claimed |
| US-20260041109-A1 | ROBUST FLAVOR EMULSIONS | INT FLAVORS & FRAGRANCES INC (US) | 2026-02-12 | — | — | US | disclosed |
| US-12419815-B2 | Microcapsule compositions stabilized with viscosity control agents | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-09-23 | — | — | US | disclosed |
| EP-4615958-A1 | CELL COMPOSITIONS | Givaudan SA (CH) | 2025-09-17 | — | — | EP | disclosed |
| US-12357547-B2 | Compositions containing microcapsules | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-07-15 | — | — | US | disclosed |
| US-12324452-B2 | Delivery systems and methods of preparing the same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-06-10 | — | — | US | disclosed |
| US-12274771-B2 | Polyurea capsule compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-04-15 | — | — | US | disclosed |
| US-12030326-B2 | System and method for printing and drying flavors and fragrances | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240180220-A1 | HYDROGEL ENCAPSULATIONS AND METHODS OF MAKING THE SAME | INTERNATIONAL FLAVORS & FRANGRANCES INC. | 2024-06-06 | — | — | US | disclosed |
| WO-2024100137-A1 | CELL COMPOSITIONS | GIVAUDAN SA (CH) | 2024-05-16 | — | — | WO | disclosed |
| EP-1761271-A1 | BLACKBERRY EXTRACT | Symrise GmbH & Co. KG (DE) | 2007-03-14 | — | — | EP | disclosed |
| WO-2006032668-A1 | USE OF AROMA SUBSTANCE MIXTURES AS AGENTS AGAINST BAD BREATH | SYMRISE GMBH & CO. KG (DE) | 2006-03-30 | — | — | WO | disclosed |
| WO-2006032667-A1 | USE OF BETA-HOMOCYCLOCITRAL AS AN AGENT AGAINST BAD BREATH | SYMRISE GMBH & CO. KG (DE) | 2006-03-30 | — | — | WO | disclosed |
| WO-2005123101-A1 | BLACKBERRY EXTRACT | SYMRISE GMBH & CO. KG (DE) | 2005-12-29 | — | — | WO | disclosed |
| US-20050244561-A1 | Carvone acetals used as flavourings | SYMRISE GMBH & CO. KG (DE) | 2005-11-03 | — | — | US | disclosed |
| US-20050234132-A1 | Production of cis-pellitorin and use as a flavouring | SYMRISE AG (DE) | 2005-10-20 | — | — | US | disclosed |
| US-20050208084-A1 | Use of alkylamidomandelates as flavourings | SYMRISE GMBH & CO. KG (DE) | 2005-09-22 | — | — | US | disclosed |
| US-20040241312-A1 | Use of 2E,4E-decadienoic acid isobutylamide for imparting a salivation inducing effect to a foodstuff, an oral hygiene preparation or a gourmet or snack preparation; preparation by amidating a dodecadienoate with isobutylamine | SYMRISE AG (DE) | 2004-12-02 | — | — | US | disclosed |
| US-6673756-B2 | MULTILAYER; CUTTING, JOINING UNDER PRESSURE | SYMRISE GMBH & CO. KG (DE) | 2004-01-06 | — | — | US | disclosed |
| US-20020173436-A1 | Multilayer; cutting, joining under pressure | SYMRISE GMBH & CO. KG (DE) | 2002-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12357547-B2 | Compositions containing microcapsules | COPE, SAAL1, AUP1 | TRPV1 4192/4885ALDH1A1 4610/4885CYP1A2 4690/4885 |
| US-12324452-B2 | Delivery systems and methods of preparing the same | MAL2, TAS2R42, TAS2R31 | TRPV1 749/4885ALDH1A1 378/4885CYP1A2 414/4885 |
| US-20050234132-A1 | Production of cis-pellitorin and use as a flavouring | NISCH, CYP8B1, DLAT | TRPV1 1061/4885ALDH1A1 429/4885CYP1A2 76/4885 |
| US-20050208084-A1 | Use of alkylamidomandelates as flavourings | HNMT, TAS2R7, PNMT | TRPV1 308/4885ALDH1A1 807/4885CYP1A2 549/4885 |
| US-12419815-B2 | Microcapsule compositions stabilized with viscosity control agents | ACR, ALG1, MLEC | TRPV1 3271/4885ALDH1A1 4627/4885CYP1A2 4836/4885 |
| US-12274771-B2 | Polyurea capsule compositions | PUF60, UMPS, PCBP1 | TRPV1 3537/4885ALDH1A1 4096/4885CYP1A2 4802/4885 |
| US-20260041109-A1 | ROBUST FLAVOR EMULSIONS | ACACA, FABP4, CUTA | TRPV1 687/4885ALDH1A1 362/4885CYP1A2 2577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.